|
|
||||||||
The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 695-705, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association
D Jablons, SM Steinberg, J Roth, S Pittaluga, SA Rosenberg and HI Pass
Between 1982 and 1987, 74 patients (46 men and 28 women) had exploration
for presumed metastases from high-grade soft tissue sarcoma of the
head/neck, extremity, or trunk. Ages ranged from 11 to 75 years (median 38
years). Thirty (41%) had multiple procedures for recurrences (range two to
six explorations). Median postthoracotomy time for the group of patients
with histologically confirmed sarcoma (n = 63) was 20.3 months. Patients
rendered free of disease at initial thoracotomy had significantly longer
postthoracotomy survival times (26.8 months median) than those with
unresectable metastatic disease (9 months median); p2 less than 0.0001).
The prognostic significance of age, sex, location of primary tumor,
disease-free interval, number of nodules on preoperative computed tomograms
or conventional linear tomograms, number of metastases resected, and the
use of postoperative chemotherapy were analyzed. In a univariate analysis,
sex, age, and location of the primary tumor did not impact significantly on
survival, nor did the use of postoperative chemotherapy. Initial
disease-free interval of 1 year or less was associated with a significantly
shorter survival time, and patients with five nodules or fewer on
preoperative computed tomography had significantly longer survival times
than patients with six nodules or more. Patients with three nodules or
fewer on linear tomography had a longer postthoracotomy survival time than
patients with four nodules or more. In patients whose malignant disease
could be completely resected, the number of nodules resected at thoracotomy
did not impact on long-term survival. According to proportional-hazards
modeling, disease-free interval, sex, resectability, and truncal location
were found to associate with length of survival after metastasis removal.
We conclude that pulmonary metastasis resection in patients with soft
tissue sarcoma is associated with long-term survival, and consistent
indicators can define which patients may benefit from these interventions.
ARTICLES
Metastasectomy for soft tissue sarcoma. Further evidence for efficacy and prognostic indicators
Surgery Branch, National Institutes of Health, Bethesda, MD 20892.
This article has been cited by other articles:
![]() |
A. M. Parsons, E. K. Ennis, B. C. Yankaskas, L. A. Parker Jr, W. B. Hyslop, and F. C. Detterbeck Helical Computed Tomography Inaccuracy in the Detection of Pulmonary Metastases: Can It Be Improved? Ann. Thorac. Surg., December 1, 2007; 84(6): 1830 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Gould, J. Fletcher, M. D. Iannettoni, W. R. Lynch, D. E. Midthun, D. P. Naidich, and D. E. Ost Evaluation of Patients With Pulmonary Nodules: When Is It Lung Cancer?: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 108S - 130S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jinbo, K. Ueda, Y. Kaneda, M. Sudo, T.-S. Li, and K. Hamano Video-assisted transcatheter lung perfusion regional chemotherapy Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 1079 - 1082. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Parsons, F. C. Detterbeck, and L. A. Parker Accuracy of Helical CT in the Detection of Pulmonary Metastases: Is Intraoperative Palpation Still Necessary? Ann. Thorac. Surg., December 1, 2004; 78(6): 1910 - 1918. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Porter, S. B. Cantor, G. L. Walsh, V. W. Rusch, D. H. Leung, A. Y. DeJesus, R. E. Pollock, M. F. Brennan, and P. W. T. Pisters Cost-effectiveness of pulmonary resection and systemic chemotherapy in the management of metastatic soft tissue sarcoma: A combined analysis from the University of Texas M. D. Anderson and Memorial Sloan-Kettering Cancer Centers J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1366 - 1372. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Stojadinovic, D. H.Y. Leung, P. Allen, J. J. Lewis, D. P. Jaques, and M. F. Brennan Primary Adult Soft Tissue Sarcoma: Time-Dependent Influence of Prognostic Variables J. Clin. Oncol., November 1, 2002; 20(21): 4344 - 4352. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Burt, D. Liu, A. Abolhoda, H. M. Ross, Y. Kaneda, E. Jara, E. S. Casper, R. J. Ginsberg, and M. F. Brennan Isolated lung perfusion for patients with unresectable metastases from sarcoma: a phase I trial Ann. Thorac. Surg., May 1, 2000; 69(5): 1542 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Antunes, J. Bernardo, M. Salete, D. Prieto, L. Eugenio, and P. Tavares Excision of pulmonary metastases of osteogenic sarcoma of the limbs Eur. J. Cardiothorac. Surg., May 1, 1999; 15(5): 592 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lee, C. H.R. Boasquevisque, M. M. Boglione, M. Hiratsuka, R. K. Scheule, J. D. Cooper, and G. A. Patterson Isolated lung liposome-mediated gene transfer produces organ-specific transgenic expression Ann. Thorac. Surg., September 1, 1998; 66(3): 903 - 907. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Temeck, L. H. Wexler, S. M. Steinberg, L. L. McClure, M. A. Horowitz, and H. I. Pass Reoperative pulmonary metastasectomy for sarcomatous pediatric histologies Ann. Thorac. Surg., September 1, 1998; 66(3): 908 - 913. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Furrer, D. Lardinois, W. Thormann, H. J. Altermatt, D. Betticher, T. Cerny, A. Fikrle, D. Mettler, U. Althaus, M. E. Burt, et al. Isolated Lung Perfusion: Single-Pass System Versus Recirculating Blood Perfusion in Pigs Ann. Thorac. Surg., May 1, 1998; 65(5): 1420 - 1425. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abolhoda, A. Brooks, S. Nawata, Y. Kaneda, H. Cheng, and M. E. Burt Isolated Lung Perfusion With Doxorubicin Prolongs Survival in a Rodent Model of Pulmonary Metastases Ann. Thorac. Surg., July 1, 1997; 64(1): 181 - 184. [Abstract] [Full Text] |
||||
![]() |
S. Nawata, A. Abolhoda, H. M. Ross, A. Brooks, and M. E. Burt Sequential Bilateral Isolated Lung Perfusion in the Rat: An Experimental Model Ann. Thorac. Surg., March 1, 1997; 63(3): 796 - 799. [Abstract] [Full Text] |
||||
![]() |
S. Nawata, N. Abecasis, H. M. Ross, A. Abolhoda, H. Cheng, K. S. Sachar, and M. E. Burt ISOLATED LUNG PERFUSION WITH MELPHALAN FOR THE TREATMENT OF METASTATIC PULMONARY SARCOMA J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1542 - 1548. [Abstract] [Full Text] |
||||
![]() |
G. B. Ratto, S. Toma, D. Civalleri, G. C. Passerone, M. Esposito, D. Zaccheo, M. Canepa, P. Romano, R. Palumbo, F. De Cian, et al. ISOLATED LUNG PERFUSION WITH PLATINUM IN THE TREATMENT OF PULMONARY METASTASES FROM SOFT TISSUE SARCOMAS J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 614 - 622. [Abstract] [Full Text] |
||||
![]() |
B. Weksler, B. Ng, J. T. Lenert, and M. E. Burt Isolated Single-Lung Perfusion: A Study of the Optimal Perfusate and Other Pharmacokinetic Factors Ann. Thorac. Surg., September 1, 1995; 60(3): 624 - 629. [Abstract] [Full Text] |
||||
![]() |
J. L. Port, S. N. Hochwald, H.-Y. Wang, and M. E. Burt Buthionine Sulfoximine Pretreatment Potentiates the Effect of Isolated Lung Perfusion With Doxorubicin Ann. Thorac. Surg., August 1, 1995; 60(2): 239 - 243. [Abstract] [Full Text] |
||||
![]() |
B. K. Temeck, L. H. Wexler, S. M. Steinberg, L. L. McClure, M. Horowitz, and H. I. Pass Metastasectomy for Sarcomatous Pediatric Histologies: Results and Prognostic Factors Ann. Thorac. Surg., June 1, 1995; 59(6): 1385 - 1390. [Abstract] [Full Text] |
||||
![]() |
B. Weksler, J. Lenert, B. Ng, and M. Burt Isolated single lung perfusion with doxorubicin is effective in eradicating soft tissue sarcoma lung metastases in a rat model J. Thorac. Cardiovasc. Surg., January 1, 1994; 107(1): 50 - 54. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |